Loading clinical trials...
Loading clinical trials...
The purpose of this study is to assess the safety and tolerability of Hu5F9-G4 in participants with solid tumors.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Gilead Sciences
NCT06132828 · Solid Tumor
NCT04570423 · Solid Tumors, Lymphoma
NCT06144671 · Solid Tumor, Adult
NCT07489378 · Very Rare Tumors, Very Rare Cancers, and more
NCT06926283 · Prostate Cancer, Other Solid Tumors, and more
Stanford Cancer Institute
Stanford, California
University of Chicago
Chicago, Illinois
START Midwest
Grand Rapids, Michigan
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions